IMPALA’s vision is to positively transform biopharmaceutical quality by applying digital and advanced analytics methodologies at scale, bringing life-changing medical solutions to patients faster.
IMPALA’s mission is to gain industry-wide adoption of digital and advanced analytics methodologies and influence standards to drive excellence in quality, by collaborating with biopharma industry leaders and health authorities to share knowledge, co-develop open-source tools, methodologies, and best practices.
Make valuable contributions to shift the quality assurance paradigm in the biopharmaceutical industry
Connect with experts across the industry
Quality Briefs
Audit Site Selection
Anomaly Detection in Clinical Data
AI Powered Regulatory Intelligence
Education
Arpana Patel2024-12-18T15:01:26-05:00December 18, 2024|News|
Arpana Patel2024-11-19T14:40:23-05:00November 19, 2024|News|
Arpana Patel2024-10-01T10:35:01-04:00October 1, 2024|News, Work Products|
Arpana Patel2024-06-27T16:04:12-04:00June 27, 2024|News|
The IMPALA Consortium provides the strategic focus for working across the Biopharmaceutical ecosystem to develop and gain industry-wide consensus for the adoption of improved QA using advanced analytics and best practices to be used across the industry; ultimately improving patient outcomes and quality care at greater efficiency and greater speed.
Copyright © | IMPALA Consortium. All Rights Reserved.